214 related articles for article (PubMed ID: 12883145)
1. A program for managing weight gain associated with atypical antipsychotics.
Vreeland B; Minsky S; Menza M; Rigassio Radler D; Roemheld-Hamm B; Stern R
Psychiatr Serv; 2003 Aug; 54(8):1155-7. PubMed ID: 12883145
[TBL] [Abstract][Full Text] [Related]
2. Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program.
Menza M; Vreeland B; Minsky S; Gara M; Radler DR; Sakowitz M
J Clin Psychiatry; 2004 Apr; 65(4):471-7. PubMed ID: 15119908
[TBL] [Abstract][Full Text] [Related]
3. Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: a 12-month follow up.
Chen CK; Chen YC; Huang YS
Psychiatry Clin Neurosci; 2009 Feb; 63(1):17-22. PubMed ID: 19067997
[TBL] [Abstract][Full Text] [Related]
4. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
[TBL] [Abstract][Full Text] [Related]
5. Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial.
Kwon JS; Choi JS; Bahk WM; Yoon Kim C; Hyung Kim C; Chul Shin Y; Park BJ; Geun Oh C
J Clin Psychiatry; 2006 Apr; 67(4):547-53. PubMed ID: 16669719
[TBL] [Abstract][Full Text] [Related]
6. [Weight gain in patients with schizophrenia and schizoaffective disorder induced by the long-term treatment with atypical antipsychotics].
Gorobets LN
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(9):52-6. PubMed ID: 18833173
[TBL] [Abstract][Full Text] [Related]
7. Weight loss in overweight patients maintained on atypical antipsychotic agents.
Centorrino F; Wurtman JJ; Duca KA; Fellman VH; Fogarty KV; Berry JM; Guay DM; Romeling M; Kidwell J; Cincotta SL; Baldessarini RJ
Int J Obes (Lond); 2006 Jun; 30(6):1011-6. PubMed ID: 16432547
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic-associated weight gain and clinical outcome parameters.
Blin O; Micallef J
J Clin Psychiatry; 2001; 62 Suppl 7():11-21. PubMed ID: 11346191
[TBL] [Abstract][Full Text] [Related]
9. Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study.
de Silva VA; Dayabandara M; Wijesundara H; Henegama T; Gunewardena H; Suraweera C; Hanwella R
J Psychopharmacol; 2015 Dec; 29(12):1255-61. PubMed ID: 26510448
[TBL] [Abstract][Full Text] [Related]
10. A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics.
Weber M; Wyne K
Schizophr Res; 2006 Mar; 83(1):95-101. PubMed ID: 16507343
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
Stip E; Tourjman V
Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
[TBL] [Abstract][Full Text] [Related]
12. Reversal of antipsychotic-associated weight gain.
O'Keefe CD; Noordsy DL; Liss TB; Weiss H
J Clin Psychiatry; 2003 Aug; 64(8):907-12. PubMed ID: 12927005
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial.
Alvarez-Jiménez M; González-Blanch C; Vázquez-Barquero JL; Pérez-Iglesias R; Martínez-García O; Pérez-Pardal T; Ramírez-Bonilla ML; Crespo-Facorro B
J Clin Psychiatry; 2006 Aug; 67(8):1253-60. PubMed ID: 16965204
[TBL] [Abstract][Full Text] [Related]
14. Effects of second generation antipsychotics on leptin and ghrelin.
Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
[TBL] [Abstract][Full Text] [Related]
15. A naturalistic multicenter trial of a 12-week weight management program for overweight and obese patients with schizophrenia or schizoaffective disorder.
Lee SJ; Choi EJ; Kwon JS
J Clin Psychiatry; 2008 Apr; 69(4):555-62. PubMed ID: 18312061
[TBL] [Abstract][Full Text] [Related]
16. The impact of weight gain on quality of life among persons with schizophrenia.
Allison DB; Mackell JA; McDonnell DD
Psychiatr Serv; 2003 Apr; 54(4):565-7. PubMed ID: 12663847
[TBL] [Abstract][Full Text] [Related]
17. Gaining: pediatric patients and use of atypical antipsychotics.
Towbin KE
Am J Psychiatry; 2006 Dec; 163(12):2034-6. PubMed ID: 17151148
[No Abstract] [Full Text] [Related]
18. The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: a randomized, double-blind, placebo-controlled clinical trial.
Ghanizadeh A; Nikseresht MS; Sahraian A
Schizophr Res; 2013 Jun; 147(1):110-115. PubMed ID: 23583010
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of behavioural interventions in managing atypical antipsychotic weight gain.
Gabriele JM; Dubbert PM; Reeves RR
Obes Rev; 2009 Jul; 10(4):442-55. PubMed ID: 19389059
[TBL] [Abstract][Full Text] [Related]
20. [Schizophrenia, obesity and pharmacotherapy-associated weight gain].
Carpiniello B; Corda E; Maccioni R; Pinna F
Clin Ter; 2008; 159(5):299-306. PubMed ID: 18998030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
